Stage IIIB Breast Cancer Terminated Phase 2 Trials for Anastrozole (DB01217)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01394211Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast CancerTreatment
NCT01776008Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast CancerTreatment
NCT01368263Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast CancerTreatment